Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Dec;66(6):1005–1014. doi: 10.1038/bjc.1992.402

Interstitial photodynamic therapy in a rat liver metastasis model.

R van Hillegersberg 1, J P Marijnissen 1, W J Kort 1, P E Zondervan 1, O T Terpstra 1, W M Star 1
PMCID: PMC1978052  PMID: 1457339

Abstract

Photodynamic therapy (PDT) of hepatic tumours has been restricted owing to the preferential retention of photosensitizers in liver tissue. We therefore investigated interstitial tumour illumination as a means of selective PDT. A piece of colon carcinoma CC531 was implanted in the liver of Wag/Rij rats. Photofrin was administered (5 mg kg-1 i.v.) 2 days before laser illumination. Tumours with a mean (+/- s.e.) diameter of 5.7 +/- 0.1 mm (n = 106, 20 days after implantation) were illuminated with 625 nm light, at 200 mW cm-1 from a 0.5 cm cylindrical diffuser and either 100, 200, 400, 800 or 1600 J cm-1. Control groups received either laser illumination only, Photofrin only or diffuser insertion only. Short-term effects were studied on the second day after illumination by light microscopy and computer-assisted integration of the circumference of damaged areas. Long-term effects were studied on day 36. To determine the biochemistry of liver damage and function, serum ASAT and ALAT levels were measured on day 1 and 2, and antipyrine clearance on day 1. Tumour and surrounding liver necrosis increased with light dose delivered (P < 0.001). Best long-term results were obtained at 800 J cm-1 with complete tumour remission in 4 out of 6 animals. No deterioration in liver function was found. The results of this study show the ability of interstitial PDT to cause major destruction of tumour tissue in the liver combined with minimal liver damage.

Full text

PDF
1005

Images in this article

1007Figure 2
on p.1007
1008Figure 3
on p.1008
1009Figure 4
on p.1009
1010Figure 5
on p.1010
1010Figure 6
on p.1010

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman N. B., Jacobs R., Bloom N. D., Poon T. T. Increased capillary flow in intrahepatic tumors due to alpha-adrenergic effects of catecholamines. Cancer. 1988 Apr 15;61(8):1550–1554. doi: 10.1002/1097-0142(19880415)61:8<1550::aid-cncr2820610811>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  2. Arnfield M. R., Tulip J., Chetner M., McPhee M. S. Optical dosimetry for interstitial photodynamic therapy. Med Phys. 1989 Jul-Aug;16(4):602–608. doi: 10.1118/1.596361. [DOI] [PubMed] [Google Scholar]
  3. Arnfield M., Gonzalez S., Lea P., Tulip J., McPhee M. Cylindrical irradiator fiber tip for photodynamic therapy. Lasers Surg Med. 1986;6(2):150–154. doi: 10.1002/lsm.1900060211. [DOI] [PubMed] [Google Scholar]
  4. Balchum O. J., Doiron D. R. Photoradiation therapy of endobronchial lung cancer. Large obstructing tumors, nonobstructing tumors, and early-stage bronchial cancer lesions. Clin Chest Med. 1985 Jun;6(2):255–275. [PubMed] [Google Scholar]
  5. Bellnier D. A., Ho Y. K., Pandey R. K., Missert J. R., Dougherty T. J. Distribution and elimination of Photofrin II in mice. Photochem Photobiol. 1989 Aug;50(2):221–228. doi: 10.1111/j.1751-1097.1989.tb04152.x. [DOI] [PubMed] [Google Scholar]
  6. Bonnett R., Berenbaum M. Porphyrins as photosensitizers. Ciba Found Symp. 1989;146:40–59. doi: 10.1002/9780470513842.ch4. [DOI] [PubMed] [Google Scholar]
  7. Bugelski P. J., Porter C. W., Dougherty T. J. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res. 1981 Nov;41(11 Pt 1):4606–4612. [PubMed] [Google Scholar]
  8. Byczkowski J. Z., Gessner T. Biological role of superoxide ion-radical. Int J Biochem. 1988;20(6):569–580. doi: 10.1016/0020-711x(88)90095-x. [DOI] [PubMed] [Google Scholar]
  9. Dailey H. A., Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J. 1984 Oct 15;223(2):441–445. doi: 10.1042/bj2230441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Doiron D. R., Svaasand L. O., Profio A. E. Light dosimetry in tissue: application to photoradiation therapy. Adv Exp Med Biol. 1983;160:63–76. doi: 10.1007/978-1-4684-4406-3_8. [DOI] [PubMed] [Google Scholar]
  11. Dougherty T. J. Photodynamic therapy--new approaches. Semin Surg Oncol. 1989;5(1):6–16. doi: 10.1002/ssu.2980050104. [DOI] [PubMed] [Google Scholar]
  12. Dougherty T. J. Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol. 1987 Jun;45(6):879–889. doi: 10.1111/j.1751-1097.1987.tb07898.x. [DOI] [PubMed] [Google Scholar]
  13. Dougherty T. J., Thoma R. E., Boyle D. G., Weishaupt K. R. Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. Cancer Res. 1981 Feb;41(2):401–404. [PubMed] [Google Scholar]
  14. Fingar V. H., Wieman T. J., Doak K. W. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res. 1990 May 1;50(9):2599–2603. [PubMed] [Google Scholar]
  15. Foote C. S. Definition of type I and type II photosensitized oxidation. Photochem Photobiol. 1991 Nov;54(5):659–659. doi: 10.1111/j.1751-1097.1991.tb02071.x. [DOI] [PubMed] [Google Scholar]
  16. Gatenby R. A., Hammond N. D., Brown D. Q. Tumor therapy with hematoporphyrin derivative and lasers via a percutaneous fiberoptic technique: preclinical experiments. Radiology. 1987 Apr;163(1):167–171. doi: 10.1148/radiology.163.1.3823432. [DOI] [PubMed] [Google Scholar]
  17. Gomer C. J., Dougherty T. J. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 1979 Jan;39(1):146–151. [PubMed] [Google Scholar]
  18. Gomer C. J. Photodynamic therapy in the treatment of malignancies. Semin Hematol. 1989 Jan;26(1):27–34. [PubMed] [Google Scholar]
  19. Gomer C. J., Rucker N., Ferrario A., Wong S. Properties and applications of photodynamic therapy. Radiat Res. 1989 Oct;120(1):1–18. [PubMed] [Google Scholar]
  20. Gutteridge J. M., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci. 1990 Apr;15(4):129–135. doi: 10.1016/0968-0004(90)90206-q. [DOI] [PubMed] [Google Scholar]
  21. Henderson B. W., Bellnier D. A. Tissue localization of photosensitizers and the mechanism of photodynamic tissue destruction. Ciba Found Symp. 1989;146:112–130. doi: 10.1002/9780470513842.ch8. [DOI] [PubMed] [Google Scholar]
  22. Holt S., Tulip J., Hamilton D., Cummins J., Fields A., Dick C. Experimental laser phototherapy of the Morris 7777 hepatoma in the rat. Hepatology. 1985 Mar-Apr;5(2):175–180. doi: 10.1002/hep.1840050203. [DOI] [PubMed] [Google Scholar]
  23. Jori G., Reddi E., Cozzani I., Tomio L. Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice. Br J Cancer. 1986 May;53(5):615–621. doi: 10.1038/bjc.1986.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jungermann K., Katz N. Functional specialization of different hepatocyte populations. Physiol Rev. 1989 Jul;69(3):708–764. doi: 10.1152/physrev.1989.69.3.708. [DOI] [PubMed] [Google Scholar]
  25. Keene J. P., Kessel D., Land E. J., Redmond R. W., Truscott T. G. Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds. Photochem Photobiol. 1986 Feb;43(2):117–120. doi: 10.1111/j.1751-1097.1986.tb09501.x. [DOI] [PubMed] [Google Scholar]
  26. Kessel D., Thompson P., Musselman B., Chang C. K. Probing the structure and stability of the tumor-localizing derivative of hematoporphyrin by reductive cleavage with LiAlH4. Cancer Res. 1987 Sep 1;47(17):4642–4645. [PubMed] [Google Scholar]
  27. Kita K., Itoshima T., Ito T., Ogawa H., Ukida M., Kitadai M., Hattori S., Mizutani S., Tanaka R., Andoh M. Photodynamic therapy of rat liver cancer: protection of the normal liver by indocyanine green. Gastroenterol Jpn. 1987 Aug;22(4):465–473. doi: 10.1007/BF02773815. [DOI] [PubMed] [Google Scholar]
  28. LIPSON R. L., BALDES E. J., OLSEN A. M. The use of a derivative of hematoporhyrin in tumor detection. J Natl Cancer Inst. 1961 Jan;26:1–11. [PubMed] [Google Scholar]
  29. Manyak M. J., Russo A., Smith P. D., Glatstein E. Photodynamic therapy. J Clin Oncol. 1988 Feb;6(2):380–391. doi: 10.1200/JCO.1988.6.2.380. [DOI] [PubMed] [Google Scholar]
  30. Marquet R. L., Westbroek D. L., Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int J Cancer. 1984 May 15;33(5):689–692. doi: 10.1002/ijc.2910330521. [DOI] [PubMed] [Google Scholar]
  31. Nishiwaki Y., Nakamura S., Sakaguchi S. New method of photosensitizer accumulation for photodynamic therapy in an experimental liver tumor. Lasers Surg Med. 1989;9(3):254–263. doi: 10.1002/lsm.1900090308. [DOI] [PubMed] [Google Scholar]
  32. Shargel L., Cheung W. M., Yu A. B. High-pressure liquid chromatographic analysis of antipyrine in small plasma samples. J Pharm Sci. 1979 Aug;68(8):1052–1054. doi: 10.1002/jps.2600680835. [DOI] [PubMed] [Google Scholar]
  33. Smith A. Mechanisms of toxicity of photoactivated artificial porphyrins. Role of porphyrin-protein interactions. Ann N Y Acad Sci. 1987;514:309–322. doi: 10.1111/j.1749-6632.1987.tb48786.x. [DOI] [PubMed] [Google Scholar]
  34. Star W. M., Marijnissen H. P., van den Berg-Blok A. E., Versteeg J. A., Franken K. A., Reinhold H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986 May;46(5):2532–2540. [PubMed] [Google Scholar]
  35. Star W., Versteeg J., van Putten W., Marijnissen H. Wavelength dependence of hematoporphyrin derivative photodynamic treatment effects on rat ears. Photochem Photobiol. 1990 Sep;52(3):547–554. doi: 10.1111/j.1751-1097.1990.tb01798.x. [DOI] [PubMed] [Google Scholar]
  36. Steele G., Jr, Ravikumar T. S. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg. 1989 Aug;210(2):127–138. doi: 10.1097/00000658-198908000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sugarbaker P. H., Kemeny N. Management of metastatic cancer to the liver. Adv Surg. 1989;22:1–56. [PubMed] [Google Scholar]
  38. Van Hillegersberg R., Kort W. J., Vermeij M., Terpstra O. T. Treatment of experimental liver metastases with a noncontact neodymium: YAG laser. J Surg Res. 1992 Aug;53(2):128–135. doi: 10.1016/0022-4804(92)90024-t. [DOI] [PubMed] [Google Scholar]
  39. Van Hillegersberg R., Kort W. J., ten Kate F. J., Terpstra O. T. Water-jet-cooled Nd:YAG laser coagulation: selective destruction of rat liver metastases. Lasers Surg Med. 1991;11(5):445–454. doi: 10.1002/lsm.1900110510. [DOI] [PubMed] [Google Scholar]
  40. Van Hillegersberg R., Van den Berg J. W., Kort W. J., Terpstra O. T., Wilson J. H. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology. 1992 Aug;103(2):647–651. doi: 10.1016/0016-5085(92)90860-2. [DOI] [PubMed] [Google Scholar]
  41. Wagman L. D., Kemeny M. M., Leong L., Terz J. J., Hill L. R., Beatty J. D., Kokal W. A., Riihimaki D. U. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol. 1990 Nov;8(11):1885–1893. doi: 10.1200/JCO.1990.8.11.1885. [DOI] [PubMed] [Google Scholar]
  42. Waldow S. M., Dougherty T. J. Interaction of hyperthermia and photoradiation therapy. Radiat Res. 1984 Feb;97(2):380–385. [PubMed] [Google Scholar]
  43. Waldow S. M., Henderson B. W., Dougherty T. J. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models. Lasers Surg Med. 1987;7(1):12–22. doi: 10.1002/lsm.1900070104. [DOI] [PubMed] [Google Scholar]
  44. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES